BCAX
Bicara Therapeutics Inc. Common StockNASDAQHealthcare$21.47+4.73%ClosedMarket Cap: $1.18B
As of 2026-04-06
Insider Statistics (Q1 2026)
Purchases
24
Sales
38
Buy/Sell Ratio
0.63
Total Bought
$2.00
Total Sold
$21.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Thu Mar 26 | Raben David | officer: Chief Medical Officer | Sell | 5,500 | $18.95 | 55,286 |
| Thu Mar 26 | Raben David | officer: Chief Medical Officer | Sell | 5,500 | $3.79 | 60,786 |
| Tue Mar 24 | Hyep Ivan | officer: Chief Financial Officer | Sell | 9,200 | $3.79 | 154,555 |
| Tue Mar 24 | Hyep Ivan | officer: Chief Financial Officer | Sell | 9,200 | $18.52 | 145,355 |
| Fri Mar 20 | Mazumdar Claire | director, officer: Chief Executive Officer | Sell | 1,596 | $3.79 | 340,988 |
| Fri Mar 20 | Mazumdar Claire | director, officer: Chief Executive Officer | Sell | 6,905 | $18.78 | 339,392 |
| Fri Mar 20 | Mazumdar Claire | director, officer: Chief Executive Officer | Sell | 6,499 | $18.84 | 339,392 |
| Fri Mar 20 | Mazumdar Claire | director, officer: Chief Executive Officer | Sell | 1,596 | $18.95 | 339,392 |
| Fri Mar 20 | Mazumdar Claire | director, officer: Chief Executive Officer | Sell | 6,499 | $3.79 | 345,891 |
| Fri Mar 20 | Mazumdar Claire | director, officer: Chief Executive Officer | Sell | 6,905 | $3.79 | 346,297 |